Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

High-dose cyclophosphamide-induced myocardial damage during BMT: assessment by positron emission tomography.

Gardner SF, Lazarus HM, Bednarczyk EM, Creger RJ, Miraldi FD, Leisure G, Green JA.

Bone Marrow Transplant. 1993 Aug;12(2):139-44.

PMID:
8401360
2.

Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings.

Kupari M, Volin L, Suokas A, Timonen T, Hekali P, Ruutu T.

Bone Marrow Transplant. 1990 Feb;5(2):91-8.

PMID:
2138043
3.

Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens.

Braverman AC, Antin JH, Plappert MT, Cook EF, Lee RT.

J Clin Oncol. 1991 Jul;9(7):1215-23.

PMID:
2045862
4.
6.

Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation.

Emminger W, Emminger-Schmidmeier W, Haas OA, Urban C, Ambros P, Peters C, Mann G, Fink FM, Ferstl G, Höcker P, et al.

Bone Marrow Transplant. 1992 May;9(5):313-8.

PMID:
1617314
7.

Effects of bone marrow transplantation on myocardial function in children.

Pihkala J, Saarinen UM, Lundström U, Salmo M, Virkola K, Virtanen K, Siimes MA, Pesonen E.

Bone Marrow Transplant. 1994 Feb;13(2):149-55.

PMID:
8205083
9.
10.

Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2010;10(16):1-80.

12.

Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2).

Copelan EA, Biggs JC, Szer J, Thompson JM, Crilley P, Brodsky I, Klein JL, Kapoor N, Harman GS, Avalos BR.

Semin Oncol. 1993 Aug;20(4 Suppl 4):33-8; quiz 39. Review.

PMID:
8342074
13.

[Specific cardiomyopathy caused by high dose cyclophosphamide immediately after bone marrow transplantation].

Mitsui H, Kitayama H, Yamagami T, Osuga Y, Teshima H, Ueda T, Hiraoka A, Nakamura H, Shibata H, Masaoka T, et al.

Rinsho Ketsueki. 1989 Mar;30(3):387-91. Japanese.

PMID:
2671436
14.

Redistribution of myocardial blood flow with topical nitroglycerin in patients with coronary artery disease.

Fallen EL, Nahmias C, Scheffel A, Coates G, Beanlands R, Garnett ES.

Circulation. 1995 Mar 1;91(5):1381-8.

15.
16.

Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia.

Uberti JP, Agovi MA, Tarima S, Haagenson M, Gandham S, Anasetti C, Baker KS, Bolwell BJ, Bornhauser M, Chan KW, Copelan E, Davies SM, Finke J, Hale GA, Kollman C, McCarthy PL, Ratanatharathorn V, Ringdén O, Weisdorf DJ, Rizzo JD.

Bone Marrow Transplant. 2011 Jan;46(1):34-43. doi: 10.1038/bmt.2010.81.

17.

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.

Spitzer TR, McAfee S, Sackstein R, Colby C, Toh HC, Multani P, Saidman S, Weyouth DW, Preffer F, Poliquin C, Foley A, Cox B, Andrews D, Sachs DH, Sykes M.

Biol Blood Marrow Transplant. 2000;6(3A):309-20.

PMID:
10905768
18.

Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients.

Belkacémi Y, Pène F, Touboul E, Rio B, Leblond V, Gorin NC, Laugier A, Gemici C, Housset M, Ozsahin M.

Strahlenther Onkol. 1998 Feb;174(2):92-104.

PMID:
9487372
19.

Regional myocardial perfusion and metabolism assessed by positron emission tomography in children with Kawasaki disease and significance of abnormal Q waves and their disappearance.

Yoshibayashi M, Tamaki N, Nishioka K, Matsumura M, Ueda T, Temma S, Yonekura Y, Yamashita K, Konishi J, Mikawa H.

Am J Cardiol. 1991 Dec 15;68(17):1638-45.

PMID:
1746466
20.

Allogeneic bone marrow transplantation following busulfan and 90 mg/kg of cyclophosphamide.

Avalos BR, Klein JL, Kapoor N, Copelan EA.

Bone Marrow Transplant. 1993 Dec;12(6):655-8.

PMID:
8136749
Items per page

Supplemental Content

Support Center